内容特定的参与移动喘教育应用程序:ASTHMAXcel PRO的现实世界分析
Serena Zhang1, Avery Gluck2, Rebecca Cone3
1Albert Einstein College of Medicine, Bronx, NY, USA.
概括
患者与ASTHMAXcel PRO等喘手机应用程序的接触有所不同. 高龄和较差的喘控制预测了更高的完成率,而语言障碍减少了参与度,为个性化的数字健康策略提供了信息.
科学领域:
- 数字健康干预措施 数字健康干预措施
- 喘自我管理的方法
- 患者参与度分析
背景情况:
- 移动健康 (mHealth) 干预提供可扩展的喘教育.
- 了解患者与特定数字内容的互动对于有效的设计至关重要.
- 关于mHealth喘应用程序的内容层面参与度的现实数据有限.
研究的目的:
- 检查与ASTHMAXcel PRO移动健康应用程序的特定内容参与的人口统计和临床预测因素.
- 确定影响用户与不同教育模块互动的因素.
- 为数字喘自我管理工具的个性化提供信息.
主要方法:
- 分析了来自109名ASTHMAXcel PRO用户的章节级参与数据.
- 使用负二项式,准波桑式和逻辑回归模型.
- 根据年龄,性别,母语,教育,并发症,喘控制和自我管理准备情况进行调整.
主要成果:
- 老年和较差的喘控制与更高的整体章节完成度相关.
- 非英语主要语言与较低的参与度有关.
- 特定的内容类别 (如理解喘,药物,监测) 显示基于用户特征 (如年龄和喘控制) 的不同参与度.
结论:
- 喘mHealth应用程序的参与受用户人口统计和临床状况的影响.
- 结果支持定制数字喘教育内容,改善可访问性,以更好地保留和自我管理.
- 个性化内容交付和语言考虑是优化移动健康干预的关键.
相关概念视频
Asthma-I: Introduction
3.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
Asthma-IV: Nursing Management
4.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
4.0K
Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma: Pathogenesis and Management
1.6K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.6K
Asthma-III: Symptoms and Complications
3.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.6K
Asthma-II: Pathophysiology and Classification
4.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K


